Prognosis
Pfizer, BioNTech Near 2020 Vaccine Target, Easing Output Concern
This article is for subscribers only.
BioNTech SE said it’s on track to produce 50 million doses of Covid-19 vaccine with partner Pfizer Inc. this year, easing concerns that they might miss production targets.
As of Friday, the companies had made the majority of the promised supply for this year, BioNTech said in a statement to Bloomberg. For next year, they’re looking for ways to increase production capacity beyond a promised 1.3 billion doses.